No question about it: social media presents a host of problems for drug and device companies. Still, for brands that manage their presence successfully, the upside potential is huge.

But what’s the secret to keeping control over your brand as people share on social media? What does an FDA-proof social media presence look like? What happens if consumers use YouTube, Twitter or Facebook to report previously unknown adverse events? How do you present balanced promotions and important safety information using social media?

Here’s how to develop a social media strategy that keeps you compliant and competitive.

No matter how fast the rules continue to change, this new FDAnews report will help drug- and devicemakers tap the power of social media.

In it, you’ll find real-world strategies for building a strong presence on Facebook, Twitter and YouTube — without giving up control over your brand or risking marketing and advertising enforcement.

With little specific guidance from the FDA, this report fills a critical gap, connecting you with the social media strategies working most effectively for today’s drug- and devicemakers.

Buy now to build a social media strategy that keeps you compliant and competitive, despite the challenges:

• How the FDA is applying its regulations to social media marketing and advertising — and tips for avoiding problems
• How to address Facebook’s new comment policy — before random comments damage your brand and trigger FDA enforcement actions
• Dos and don’ts for keeping messaging balanced and in compliance
• Best practices from today’s safest and most successful social media campaigns
• How to handle adverse events reported via social media
• How to trouble shoot other risks and challenges most effectively

Today’s market realities demand that you tap the power of social media marketing and communications. Rely on this report to take the guesswork out of success.  Order your copy today.

Buy Now!
Offered by FDAnews in print or PDF format for $377 each.

Satisfaction Guaranteed
There's no risk when you purchase from FDAnews with our money-back guarantee. Not satisfied with your publication? Return the hard copy within 30 days (in resalable condition), and we will refund 100 percent of your purchase price (less shipping/handling). For the PDF version, you must notify FDAnews within 24 hours of receipt of purchase to receive a refund.